Mignar

Mignar (Miglitol) is used in the treatment of NIDDM (non-insulin-dependent diabetes mellitus). Its primary function is to stop the occurrence of PPHG (postprandial hyperglycemia), the medical term for high blood sugar following food consumption. The active ingredient in this medication is a type of oral alpha glucosidase inhibitor derived from desoxynojirimycin. When administered orally, it causes a reduction in the amount of sugar absorbed into the blood after you eat a meal. However, this effect is not due to stimulating the release of insulin. Instead, carbohydrates are prevented from being digested into monosaccharides (a form of sugar that can be easily absorbed into the blood), thereby preventing a rise in blood sugar after eating.

Mignar (Miglitol) tablets need to be taken exactly as your physician tells you. It is available as 25mg and 50mg tablets. The tablets must be taken at the start of each main meal. This is to ensure that blood sugar levels are effectively controlled after eating. Your physician will individualize the dosage based on your requirements. Adult patients are sometimes told to begin treatment with 25mg administered 3 times per day (alongside meals). This dosage may be further adjusted if your physician believes that this is necessary. However, do not increase your dosage unless your physician specifically directs you to.

Some side effects which have been reported by patients undergoing treatment with Mignar (Miglitol) include:

• Gas
• Pain occurring in the stomach
• Passing stools which are loose
• Mild symptoms affecting the skin
• Gastrointestinal reactions causing pain

Patients must report any side effects that occur to their physician. Serious reactions are considered to be a less common occurrence. However, if any severe side effects occur during treatment, medical treatment will be needed as soon as possible.

Patients with type 2 diabetes should be aware of the fact that the most important part of any treatment plan is diet. Those who are overweight will usually be directed to restrict their calorie intake and lose weight. Regular exercise is also essential. Follow all instructions provided by your physician.

Blood and urine tests may be required by your physician, and it may also be necessary to measure glycosylated hemoglobin levels. Attend all scheduled medical appointments.